About
Profile
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
JNJ
The stock fell slightly even after the pharmaceutical giant topped quarterly earnings expectations and benefitted from a jump in medical device sales. Revenue came in at $21.38 billion, roughly in line with the $21.4 billion expected by analysts polled by LSEG.
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Johnson & Johnson posts Q2 beat as Pharma, MedTech outperform
- Johnson & Johnson Non-GAAP EPS of $2.80 beats by $0.18, revenue of $25.53B beats by $860M
- J&J looks to continue long streak of EPS beats with Q2 results
- J&J ordered to pay $18.8M over baby powder cancer claim, jury rules (update)
- J&J becomes latest Big Pharma to sue over Medicare drug pricing
- Nanobiotix partners with J&J's Janssen for radiotherapy treatment
- Atrial fibrillation drug market expected to decline as brand therapies go generic
- Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown
- Earnings week ahead: Tesla, Netflix, Johnson & Johnson, Bank of America and more
- FDA classifies J&J electrode recall as most serious type
- Goldman Sachs sees rays of hope in underperforming health sector
- Bausch + Lomb buys Blink eye drops from Johnson & Johnson
- Johnson & Johnson psoriasis pill disappoints in phase 2 trial
- Medicare revises guidance on drug price negotiations amid lawsuits
- Morgan Stanley shakes up its global dividend portfolio
- J&J submits application to EMA for combination PAH drug
- What is behind big pharma's underperformance?
- J&J talc bankruptcy unit to establish $750M trust fund with insurers
- Cidara gains as FDA grants fast track status for flu candidate
- Top pharma lobby sues U.S. govt. over Medicare drug pricing negotiations
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| January 25, 2022 | 2.13 / 2.12 | 24.8B / 25.28B | |
| October 19, 2021 | 2.6 / 2.35 | 23.34B / 23.64B | |
| July 21, 2021 | 2.48 / 2.29 | 23.31B / 22.49B |
Beat! |
| April 20, 2021 | 2.59 / 2.34 | 22.32B / 21.98B |
Beat! |
| January 26, 2021 | 1.86 / 1.82 | 22.48B / 21.66B |
Beat! |
| October 13, 2020 | 2.2 / 1.98 | 21.08B / 20.2B |
Beat! |
| July 16, 2020 | 1.67 / 1.49 | 18.34B / 17.61B |
Beat! |
| April 14, 2020 | 2.3 / 2.02 | 20.69B / 19.73B |
Beat! |
| January 22, 2020 | 1.88 / 1.87 | 20.75B / 20.8B | |
| October 15, 2019 | 2.12 / 2.01 | 20.73B / 20.08B |
Beat! |
| July 16, 2019 | 2.58 / 2.46 | 20.56B / 20.29B |
Beat! |
| April 16, 2019 | 2.1 / 2.04 | 20.02B / 19.61B |
Beat! |
| January 22, 2019 | 1.97 / 1.95 | 20.39B / 20.2B |
Beat! |
| October 16, 2018 | 2.05 / 2.03 | 20.35B / 20.05B |
Beat! |
| July 17, 2018 | 2.1 / 2.07 | 20.83B / 20.42B |
Beat! |
| April 17, 2018 | 2.06 / 2 | 20.01B / 19.49B |
Beat! |
| January 23, 2018 | 1.74 / 1.72 | 20.2B / 20,072M | |
| October 17, 2017 | 1.9 / 1.80 | 19.65B / 19,283M | |
| July 18, 2017 | 1.83 / 1.80 | 18.84B / 18,935M | |
| April 18, 2017 | 1.83 / 1.77 | 17.77B / 18,037M |
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 9, 2023 | 158.54 | 157.18 |
158.88
|
157.09
|
4.4M | 0.57% | ||||
| Oct 6, 2023 | 157.64 | 157.08 |
158.3
|
156.59
|
5.8M | 0.32% | ||||
| Oct 5, 2023 | 157.14 | 156.27 |
158.04
|
156.07
|
6.0M | 1.04% | ||||
| Oct 4, 2023 | 155.52 | 155.57 |
155.93
|
154.57
|
4.9M | 0.12% | ||||
| Oct 3, 2023 | 155.34 | 154.68 |
155.49
|
153.89
|
5.7M | 0.12% | ||||
| Oct 2, 2023 | 155.15 | 155.42 |
155.42
|
153.32
|
6.3M | -0.39% | ||||
| Sep 29, 2023 | 155.75 | 157.37 |
157.6
|
155.35
|
7.7M | -0.72% | ||||
| Sep 28, 2023 | 156.88 | 157.5 |
157.96
|
156.22
|
7.9M | -0.15% | ||||
| Sep 27, 2023 | 157.11 | 158.58 |
158.76
|
155.26
|
9.2M | -1.2% | ||||
| Sep 26, 2023 | 159.02 | 159.81 |
160.08
|
158.86
|
4.9M | -0.77% | ||||
| Sep 25, 2023 | 160.26 | 160.07 |
160.36
|
158.73
|
6.7M | -0.15% | ||||
| Sep 22, 2023 | 160.5 | 161.3 |
161.4
|
160.25
|
5.0M | -0.72% | ||||
| Sep 21, 2023 | 161.66 | 162.57 |
163.5
|
161.59
|
4.5M | -0.77% | ||||
| Sep 20, 2023 | 162.91 | 162.19 |
163.54
|
161.66
|
3.8M | 0.44% | ||||
| Sep 19, 2023 | 162.2 | 162.25 |
162.85
|
161.38
|
5.6M | -0.17% | ||||
| Sep 18, 2023 | 162.47 | 162.12 |
163.15
|
160.75
|
5.8M | 0.63% | ||||
| Sep 15, 2023 | 161.45 | 163.98 |
164.82
|
161.21
|
13.4M | -1.4% | ||||
| Sep 14, 2023 | 163.74 | 164.68 |
165.27
|
163.44
|
7.7M | -0.15% | ||||
| Sep 13, 2023 | 163.99 | 163.76 |
164.95
|
163
|
7.4M | 0.25% | ||||
| Sep 12, 2023 | 163.58 | 162.22 |
163.93
|
161.53
|
6.0M | 0.57% | ||||
| Sep 11, 2023 | 162.66 | 161.06 |
162.69
|
160.45
|
6.3M | 1.31% | ||||
| Sep 8, 2023 | 160.56 | 159.59 |
160.68
|
159.19
|
6.9M | 0.33% | ||||
| Sep 7, 2023 | 160.03 | 159.14 |
161.06
|
158.98
|
9.9M | 1.28% | ||||
| Sep 6, 2023 | 158.01 | 159.84 |
160
|
157.35
|
9.8M | -1.66% | ||||
| Sep 5, 2023 | 160.68 | 160.56 |
161.97
|
160.28
|
9.0M | 0.12% | ||||
| Sep 1, 2023 | 160.48 | 161.42 |
162.48
|
160.01
|
8.6M | -0.74% | ||||
| Aug 31, 2023 | 161.68 | 163.37 |
163.57
|
161.28
|
11.1M | -1.25% | ||||
| Aug 30, 2023 | 163.73 | 165.11 |
165.83
|
163.68
|
9.2M | -0.35% | ||||
| Aug 29, 2023 | 164.31 | 164.87 |
165.68
|
162.77
|
12.2M | 0.01% | ||||
| Aug 28, 2023 | 164.29 | 165 |
166.21
|
163.16
|
18.5M | -1.18% | ||||
| Aug 25, 2023 | 166.25 | 164.3 |
167.78
|
164.06
|
18.2M | 0.70% | ||||
| Aug 24, 2023 | 165.09 | 164.03 |
166.67
|
163.86
|
65.2M | 0.34% | ||||
| Aug 23, 2023 | 164.53 | 165.9 |
166.5
|
163.47
|
114M | -0.9% | ||||
| Aug 22, 2023 | 166.02 | 166.86 |
167.84
|
165.41
|
56.1M | -0.79% | ||||
| Aug 21, 2023 | 167.35 | 169.69 |
169.85
|
165.96
|
142M | -2.98% | ||||
| Aug 18, 2023 | 172.49 | 173.17 |
173.99
|
171.31
|
49.6M | -0.87% | ||||
| Aug 17, 2023 | 174.01 | 172.86 |
175.39
|
172.76
|
68.0M | 0.94% | ||||
| Aug 16, 2023 | 172.39 | 172.53 |
174.73
|
172.13
|
85.8M | -0.32% | ||||
| Aug 15, 2023 | 172.94 | 172.8 |
174.56
|
172.14
|
88.9M | -0.29% | ||||
| Aug 14, 2023 | 173.44 | 173.52 |
175.6
|
171.75
|
62.6M | -0.24% | ||||
| Aug 11, 2023 | 173.85 | 172.48 |
173.95
|
171.62
|
45.9M | 0.98% | ||||
| Aug 10, 2023 | 172.17 | 174 |
175.97
|
171.64
|
48.1M | -0.52% | ||||
| Aug 9, 2023 | 173.07 | 173 |
174.25
|
172.05
|
42.7M | -0.06% | ||||
| Aug 8, 2023 | 173.18 | 172.99 |
173.55
|
171.39
|
24.2M | 0.05% | ||||
| Aug 7, 2023 | 173.1 | 169.49 |
173.34
|
169.36
|
17.5M | 2.40% | ||||
| Aug 4, 2023 | 169.04 | 170.34 |
172.68
|
167.89
|
23.4M | -0.94% | ||||
| Aug 3, 2023 | 170.64 | 169.95 |
171.32
|
169.67
|
16.9M | 0.43% | ||||
| Aug 2, 2023 | 169.91 | 168.85 |
171.24
|
168.85
|
14.2M | 0.60% | ||||
| Aug 1, 2023 | 168.89 | 166.37 |
169.09
|
166.06
|
15.8M | 0.81% | ||||
| Jul 31, 2023 | 167.53 | 169.69 |
170.22
|
166.71
|
22.5M | -3.98% | ||||
| Jul 28, 2023 | 174.48 | 174 |
175.36
|
173.23
|
14.1M | 0.45% | ||||
| Jul 27, 2023 | 173.69 | 172.18 |
174.29
|
172.04
|
12.4M | 0.56% | ||||
| Jul 26, 2023 | 172.72 | 172 |
173.85
|
171.4
|
14.3M | 0.19% | ||||
| Jul 25, 2023 | 172.39 | 170.45 |
172.68
|
169.75
|
13.8M | 0.77% | ||||
| Jul 24, 2023 | 171.08 | 171.5 |
173.82
|
170.99
|
15.2M | 0.52% | ||||
| Jul 21, 2023 | 170.19 | 168.18 |
170.82
|
168.18
|
12.1M | 1.07% | ||||
| Jul 20, 2023 | 168.38 | 161.94 |
169.14
|
161.3
|
21.9M | 6.07% | ||||
| Jul 19, 2023 | 158.74 | 157.91 |
160.41
|
157.33
|
7.5M | -0.2% | ||||
| Jul 18, 2023 | 159.06 | 159.07 |
160.89
|
158.19
|
6.3M | -0.01% | ||||
| Jul 17, 2023 | 159.07 | 159.75 |
159.87
|
158.15
|
5.4M | 0% | ||||